title: Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma.
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Higo
authors.forename: Tomomitsu
authors.initials: T
authors.lastname: Miyagaki
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Nakamura
authors.forename: Akihito
authors.initials: A
authors.lastname: Shinohara
authors.forename: Hiroki
authors.initials: H
authors.lastname: Asano
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Abe
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Senda
authors.forename: Ayumi
authors.initials: A
authors.lastname: Yoshizaki
authors.forename: Masashi
authors.initials: M
authors.lastname: Fukayama
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D003875:Drug Eruptions / Q000175:diagnosis; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D010257:Paraneoplastic Syndromes / Q000139:chemically induced* / Q000175:diagnosis; D010392:Pemphigus / Q000139:chemically induced* / Q000175:diagnosis; D012008:Recurrence; D000069283:Rituximab; D016879:Salvage Therapy / Q000009:adverse effects
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride